ADmark® Early Onset Alzheimer's Evaluation

Test Code

Test Details

Test code: 179
Type of disorder: Dementia
Disease(s) tested for: Alzheimer's Disease
Genes Included: APP, PSEN1, PSEN2
Tests included:
Informed Consent Required: This test requires physician attestation that patient consent has been received

Technical Information

Clinical Significance: Detects sequence variants in the PS-1, PS-2, and APP genes. Detects duplications in the APP gene.

Typical Presentation: Progressive dementia with onset before age 65 with a positive family history of early-onset Alzheimer's disease
Methodology: Next Generation Sequencing, Dosage Analysis
Reference Range: No sequence variation detected

CPT Coding

The CPT codes provided are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payer being billed.

CPT: 81405(1), 81406(2), 81479(1)

Specimen Requirements

Please label each specimen tube with two forms of patient identification. These forms of identification must also appear on the requisition form.

Specimen Type: Whole blood
Specimen Stability: Room temperature: 10 days, Refrigerated: 10 days, Frozen: Unacceptable
Specimen Requirements: 8 mL (6 mL minimum) whole blood collected in two (lavender-top) EDTA tubes.
Instructions: Higher blood volumes ensure adequate DNA quantity, which varies with WBC, specimen condition, and need for confirmatory testing.

Shipping Considerations

Transport Temperature: Room temperature
Set-up/Analytic Time: 21-28 days

Additional Resources

Letters of Medical Necessity

Subscribe to Test Menu Updates

You'll get notified for all critical test updates.

Sign Up

Register With Athena Diagnostics

Saved profiles, requisition order history, supply order history and easy reordering!


Need Help?